During the past decade, Icahn School of Medicine at Mount Sinai-Department of Dermatology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Icahn School of Medicine at Mount Sinai-Department of Dermatology" are "Plaque Psoriasis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Icahn School of Medicine at Mount Sinai-Department of Dermatology" in a lesser frequency.

Most popular intervention types in "Icahn School of Medicine at Mount Sinai-Department of Dermatology" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (1 trials), "Deucravacitinib" (1 trials), "Lac-Hydrin lotion (ammonium lactate lotion 12%) ; UItravate ointment (halobetasol propionate ointment 0.05%)" (1 trials), "Lac-Hydrin lotion (ammonium lactate lotion 12%); placebo ointment" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icahn School of Medicine at Mount Sinai-Department of Dermatology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Icahn School of Medicine at Mount Sinai-Department of Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Icahn School of Medicine at Mount Sinai-Department of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icahn School of Medicine at Mount Sinai-Department of Dermatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".